Literature DB >> 12010313

Continent urinary reservoir formation with transverse colon for patients with pelvic irradiation.

Haruaki Kato1, Yasuhiko Igawa, Itsuki Komiyama, Osamu Nishizawa.   

Abstract

BACKGROUND: The creation of a continent transverse colon pouch for patients who had previously received radiation therapy for cervical cancer was attempted.
METHODS: Three patients underwent construction of a continent urinary reservoir. Approximately 30 cm of a transverse colon segment was isolated for constructing a pouch. A reconfigured colon segment was used in two cases as a continent valve and the appendix was used in one case. Both ureters were implanted submucosally into the pouch in two patients and a reconfigured colon was also used to reconstruct a defect of the ureter in one patient.
RESULTS: All patients could catheterize the pouch easily via the cutaneous stoma without incontinence. No complications were noted.
CONCLUSIONS: In the event that a urinary diversion is necessary for a patient who has previously had radiation therapy, the transverse colon pouch can be a useful method to improve the quality of life. In addition, versatility of the reconfigured colon segment enables the colon pouch to be adapted to adverse clinical situations.

Entities:  

Mesh:

Year:  2002        PMID: 12010313     DOI: 10.1046/j.1442-2042.2002.00448.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  2 in total

1.  [Urinary diversion and colon: transverse conduit and transverse pouch].

Authors:  S A Ahyai; K Sayedahmed; O Engel; F Chun; R Dahlem; M Fisch
Journal:  Urologe A       Date:  2012-07       Impact factor: 0.639

2.  Continent urinary diversion in patients with pelvic irradiation: an alternative utilizing transverse colon reservoir.

Authors:  Carlos Arturo Levi D'Ancona; Armando Radesca Cavaller; Ubirajara Ferreira; Victor Augusto; Sanguinetti Scherrer Leitão; Renato Nardi Pedro; Nelson Rodrigues Netto
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.